Condition: Endocrine Disease · Metabolic Disorders · Hypertension · Sponsor: Qifu Li
The aim is to establish an effective and practical early warning model for endocrine and metabolic diseases based on an environmental-gene-protein panoramic network, to uncover new mechanisms underlying the onset and progression of these diseases, and to screen for novel therapeutic targets.
This description comes directly from the study's public registry record.
Qifu Li, MD, PhD, Chief Physician · +8618696676815 · liqifu@yeah.net
Shumin Yang, MD, PhD, Chief Physician · +8615523552235 · 443068494@qq.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Chongqing Medical University | Chongqing, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07512609